BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Down 93.3% in March

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,000 shares, a drop of 93.3% from the February 28th total of 15,000 shares. Based on an average daily trading volume, of 16,000 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are short sold.

BioNxt Solutions Stock Down 9.3 %

BNXTF traded down $0.04 on Wednesday, reaching $0.39. 200 shares of the company traded hands, compared to its average volume of 10,215. The company has a market cap of $44.50 million, a P/E ratio of -9.81 and a beta of 0.62. The firm has a fifty day simple moving average of $0.34 and a two-hundred day simple moving average of $0.25. BioNxt Solutions has a one year low of $0.11 and a one year high of $0.43.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.